Product Code: ETC6185604 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The motion sickness treatment market in Australia is driven by the high frequency of domestic and international travel, as well as the country`s large coastal population engaging in marine activities. Over-the-counter medications such as antihistamines dominate, while alternative therapies including acupuncture and ginger-based products are gaining popularity. Public awareness campaigns and health-focused travel tips also support the markets growth.
The motion sickness treatment market in Australia is expanding with increased awareness and travel frequency, both by sea and air. Consumer preference is shifting toward natural and over-the-counter remedies, including ginger-based products and wearable acupressure devices. The pharmaceutical segment continues to innovate with longer-lasting and less sedative medications.
This market is challenged by consumer preference for non-pharmaceutical remedies, such as acupressure bands and herbal solutions, which compete with traditional medications. Regulatory restrictions on certain active ingredients and the need for updated clinical data hinder the development of new pharmaceutical treatments. Moreover, awareness levels around motion sickness vary across demographics, affecting consistent demand. Side effects and varying efficacy across individuals also affect consumer trust in pharmaceutical options.
Australias active tourism and marine travel sectors support investment opportunities in motion sickness treatment products. Investors can look into developing or distributing natural, wearable, or fast-acting treatment options. Funding e-commerce platforms that specialize in health and travel wellness products, or supporting local pharmacies with private-label products, can be profitable approaches.
In the motion sickness treatment market, government policies primarily focus on the regulation of pharmaceuticals and medical devices. The Therapeutic Goods Administration (TGA) controls the approval and sale of motion sickness treatments, which can slow down the introduction of new drugs and treatments. The government also regulates advertising and labeling for over-the-counter treatments, which affects how companies market their products. Policies that govern the use of natural remedies and herbal treatments are also relevant, as some products in this category may not undergo the same rigorous testing as pharmaceuticals. Additionally, policies encouraging the development of non-drug solutions, such as therapies or wearables, could create new opportunities for the market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Motion Sickness Treatment Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Motion Sickness Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Motion Sickness Treatment Market - Industry Life Cycle |
3.4 Australia Motion Sickness Treatment Market - Porter's Five Forces |
3.5 Australia Motion Sickness Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Motion Sickness Treatment Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.7 Australia Motion Sickness Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Motion Sickness Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Motion Sickness Treatment Market Trends |
6 Australia Motion Sickness Treatment Market, By Types |
6.1 Australia Motion Sickness Treatment Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Motion Sickness Treatment Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Motion Sickness Treatment Market Revenues & Volume, By Anticholinergic, 2021- 2031F |
6.1.4 Australia Motion Sickness Treatment Market Revenues & Volume, By Antihistamines, 2021- 2031F |
6.1.5 Australia Motion Sickness Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Motion Sickness Treatment Market, By Administration |
6.2.1 Overview and Analysis |
6.2.2 Australia Motion Sickness Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Australia Motion Sickness Treatment Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.2.4 Australia Motion Sickness Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Motion Sickness Treatment Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Australia Motion Sickness Treatment Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.3 Australia Motion Sickness Treatment Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.3.4 Australia Motion Sickness Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Motion Sickness Treatment Market Import-Export Trade Statistics |
7.1 Australia Motion Sickness Treatment Market Export to Major Countries |
7.2 Australia Motion Sickness Treatment Market Imports from Major Countries |
8 Australia Motion Sickness Treatment Market Key Performance Indicators |
9 Australia Motion Sickness Treatment Market - Opportunity Assessment |
9.1 Australia Motion Sickness Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Motion Sickness Treatment Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.3 Australia Motion Sickness Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Motion Sickness Treatment Market - Competitive Landscape |
10.1 Australia Motion Sickness Treatment Market Revenue Share, By Companies, 2024 |
10.2 Australia Motion Sickness Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |